Abbott secures CE Mark approval for Tendyne heart valve
Tendyne TMVI system is indicated for treating mitral regurgitation (MR) in patients, who need heart valve replacement and…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
31 Jan 20
Tendyne TMVI system is indicated for treating mitral regurgitation (MR) in patients, who need heart valve replacement and…
31 Jan 20
The new implantable heart devices are compatible with the TriageHF technology
31 Jan 20
Nihon Kohden has envisioned, designed and produced revolutionary devices, such as pulse oximeters, arrhythmia analysis, low-invasive blood volume…
31 Jan 20
STATKING Clinical Services provides biostatistics and clinical data management for clinical trials for the regulatory approval of novel…
30 Jan 20
The drug-device combination works by polarising the drug, dubbed 129Xenon, enabling functional, regional and quantitative imaging of the…
30 Jan 20
IRIS is one of six initial grantees for the AI for Health initiative and is honoured to be…
30 Jan 20
Lyra develops integrated drug and delivery solutions for localised treatment of patients with ear, nose and throat (ENT)…
30 Jan 20
CytoSorb has been approved with expanded label indication for the removal of the anti-platelet agent ticagrelor, during cardiopulmonary…
30 Jan 20
VADovations is developing ultra-miniaturized blood pumps designed for minimally invasive and percutaneous, endovascular deployment while addressing the total…
30 Jan 20
Nuance provides intelligent systems that support a more natural and insightful approach to clinical documentation, freeing clinicians to…